Levobetaxolol-induced up-regulation of retinal bFGF and CNTF mRNAs and preservation of retinal function against a photic-induced retinopathy

Neeraj Agarwal, Elizabeth Martin, Raghu Krishnamoorthy, Robert Landers, Rong Wen, Scott Krueger, Michael A. Kapin, Robert J. Collier

Research output: Contribution to journalArticleResearchpeer-review

20 Citations (Scopus)

Abstract

Betaxolol (racemic), a β-adrenoceptor antagonist that is used to lower intraocular pressure in the treatment of glaucoma, has been shown to protect inner retina cells from various insults. To determine if such protection could be afforded to retinal photoreceptors and retinal pigment epithelial cells (RPE), levobetaxolol (S-betaxolol) was evaluated in a photic-induced retinopathy model. Rats were dosed (IP) with vehicle or levobetaxolol (10 and 20 mg kg-1) 48, 24 and 0 hr prior to exposure for 6 hr to fluorescent blue light. The electroretinogram (ERG) and retinal morphology were assessed after a 3 week recovery period. Evaluation of the ERG demonstrated significant protection of retinal function in levobetaxolol (20 mg kg-1)-dosed rats compared to vehicle-dosed rats. Similarly, the RPE and outer nuclear layer were significantly thicker in levobetaxolol (20 mg kg-1)-dosed rats compared to vehicle-dosed rats. To elucidate potential mechanism(s) of the neuroprotective activity of levobetaxolol, bFGF and CNTF mRNA levels in normal rat retinas were evaluated 12 hr after a single i.p. injection. Northern blot analysis of levobetaxolol treated retinas demonstrated a 10-fold up-regulation of bFGF and a two-fold up-regulation of CNTF mRNA levels, trophic factors that have been shown to inhibit retinal degeneration in a number of species. These studies suggest that levobetaxolol can be used as a novel neuroprotective agent to ameliorate retinopathy.

Original languageEnglish
Pages (from-to)445-453
Number of pages9
JournalExperimental eye research
Volume74
Issue number4
DOIs
StatePublished - 1 Jan 2002

Fingerprint

Ciliary Neurotrophic Factor
Up-Regulation
Messenger RNA
Retinal Pigments
Betaxolol
Retina
Epithelial Cells
Retinal Degeneration
Neuroprotective Agents
Intraocular Pressure
Northern Blotting
Glaucoma
Adrenergic Receptors
Light
Injections

Keywords

  • CNTF
  • Levobetaxolol
  • Light damage
  • Neuroprotection
  • Photoreceptors
  • Retinopathy
  • bFGF

Cite this

Agarwal, Neeraj ; Martin, Elizabeth ; Krishnamoorthy, Raghu ; Landers, Robert ; Wen, Rong ; Krueger, Scott ; Kapin, Michael A. ; Collier, Robert J. / Levobetaxolol-induced up-regulation of retinal bFGF and CNTF mRNAs and preservation of retinal function against a photic-induced retinopathy. In: Experimental eye research. 2002 ; Vol. 74, No. 4. pp. 445-453.
@article{4ebbdcee2c9246ffaa4cff9fe68245aa,
title = "Levobetaxolol-induced up-regulation of retinal bFGF and CNTF mRNAs and preservation of retinal function against a photic-induced retinopathy",
abstract = "Betaxolol (racemic), a β-adrenoceptor antagonist that is used to lower intraocular pressure in the treatment of glaucoma, has been shown to protect inner retina cells from various insults. To determine if such protection could be afforded to retinal photoreceptors and retinal pigment epithelial cells (RPE), levobetaxolol (S-betaxolol) was evaluated in a photic-induced retinopathy model. Rats were dosed (IP) with vehicle or levobetaxolol (10 and 20 mg kg-1) 48, 24 and 0 hr prior to exposure for 6 hr to fluorescent blue light. The electroretinogram (ERG) and retinal morphology were assessed after a 3 week recovery period. Evaluation of the ERG demonstrated significant protection of retinal function in levobetaxolol (20 mg kg-1)-dosed rats compared to vehicle-dosed rats. Similarly, the RPE and outer nuclear layer were significantly thicker in levobetaxolol (20 mg kg-1)-dosed rats compared to vehicle-dosed rats. To elucidate potential mechanism(s) of the neuroprotective activity of levobetaxolol, bFGF and CNTF mRNA levels in normal rat retinas were evaluated 12 hr after a single i.p. injection. Northern blot analysis of levobetaxolol treated retinas demonstrated a 10-fold up-regulation of bFGF and a two-fold up-regulation of CNTF mRNA levels, trophic factors that have been shown to inhibit retinal degeneration in a number of species. These studies suggest that levobetaxolol can be used as a novel neuroprotective agent to ameliorate retinopathy.",
keywords = "CNTF, Levobetaxolol, Light damage, Neuroprotection, Photoreceptors, Retinopathy, bFGF",
author = "Neeraj Agarwal and Elizabeth Martin and Raghu Krishnamoorthy and Robert Landers and Rong Wen and Scott Krueger and Kapin, {Michael A.} and Collier, {Robert J.}",
year = "2002",
month = "1",
day = "1",
doi = "10.1006/exer.2001.1145",
language = "English",
volume = "74",
pages = "445--453",
journal = "Experimental Eye Research",
issn = "0014-4835",
publisher = "Academic Press Inc.",
number = "4",

}

Levobetaxolol-induced up-regulation of retinal bFGF and CNTF mRNAs and preservation of retinal function against a photic-induced retinopathy. / Agarwal, Neeraj; Martin, Elizabeth; Krishnamoorthy, Raghu; Landers, Robert; Wen, Rong; Krueger, Scott; Kapin, Michael A.; Collier, Robert J.

In: Experimental eye research, Vol. 74, No. 4, 01.01.2002, p. 445-453.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Levobetaxolol-induced up-regulation of retinal bFGF and CNTF mRNAs and preservation of retinal function against a photic-induced retinopathy

AU - Agarwal, Neeraj

AU - Martin, Elizabeth

AU - Krishnamoorthy, Raghu

AU - Landers, Robert

AU - Wen, Rong

AU - Krueger, Scott

AU - Kapin, Michael A.

AU - Collier, Robert J.

PY - 2002/1/1

Y1 - 2002/1/1

N2 - Betaxolol (racemic), a β-adrenoceptor antagonist that is used to lower intraocular pressure in the treatment of glaucoma, has been shown to protect inner retina cells from various insults. To determine if such protection could be afforded to retinal photoreceptors and retinal pigment epithelial cells (RPE), levobetaxolol (S-betaxolol) was evaluated in a photic-induced retinopathy model. Rats were dosed (IP) with vehicle or levobetaxolol (10 and 20 mg kg-1) 48, 24 and 0 hr prior to exposure for 6 hr to fluorescent blue light. The electroretinogram (ERG) and retinal morphology were assessed after a 3 week recovery period. Evaluation of the ERG demonstrated significant protection of retinal function in levobetaxolol (20 mg kg-1)-dosed rats compared to vehicle-dosed rats. Similarly, the RPE and outer nuclear layer were significantly thicker in levobetaxolol (20 mg kg-1)-dosed rats compared to vehicle-dosed rats. To elucidate potential mechanism(s) of the neuroprotective activity of levobetaxolol, bFGF and CNTF mRNA levels in normal rat retinas were evaluated 12 hr after a single i.p. injection. Northern blot analysis of levobetaxolol treated retinas demonstrated a 10-fold up-regulation of bFGF and a two-fold up-regulation of CNTF mRNA levels, trophic factors that have been shown to inhibit retinal degeneration in a number of species. These studies suggest that levobetaxolol can be used as a novel neuroprotective agent to ameliorate retinopathy.

AB - Betaxolol (racemic), a β-adrenoceptor antagonist that is used to lower intraocular pressure in the treatment of glaucoma, has been shown to protect inner retina cells from various insults. To determine if such protection could be afforded to retinal photoreceptors and retinal pigment epithelial cells (RPE), levobetaxolol (S-betaxolol) was evaluated in a photic-induced retinopathy model. Rats were dosed (IP) with vehicle or levobetaxolol (10 and 20 mg kg-1) 48, 24 and 0 hr prior to exposure for 6 hr to fluorescent blue light. The electroretinogram (ERG) and retinal morphology were assessed after a 3 week recovery period. Evaluation of the ERG demonstrated significant protection of retinal function in levobetaxolol (20 mg kg-1)-dosed rats compared to vehicle-dosed rats. Similarly, the RPE and outer nuclear layer were significantly thicker in levobetaxolol (20 mg kg-1)-dosed rats compared to vehicle-dosed rats. To elucidate potential mechanism(s) of the neuroprotective activity of levobetaxolol, bFGF and CNTF mRNA levels in normal rat retinas were evaluated 12 hr after a single i.p. injection. Northern blot analysis of levobetaxolol treated retinas demonstrated a 10-fold up-regulation of bFGF and a two-fold up-regulation of CNTF mRNA levels, trophic factors that have been shown to inhibit retinal degeneration in a number of species. These studies suggest that levobetaxolol can be used as a novel neuroprotective agent to ameliorate retinopathy.

KW - CNTF

KW - Levobetaxolol

KW - Light damage

KW - Neuroprotection

KW - Photoreceptors

KW - Retinopathy

KW - bFGF

UR - http://www.scopus.com/inward/record.url?scp=0036310830&partnerID=8YFLogxK

U2 - 10.1006/exer.2001.1145

DO - 10.1006/exer.2001.1145

M3 - Article

VL - 74

SP - 445

EP - 453

JO - Experimental Eye Research

JF - Experimental Eye Research

SN - 0014-4835

IS - 4

ER -